InsidersTradesSigma
Track the Cartesian Therapeutics, Inc. stock price and the full management transaction log of the company, a publicly traded company based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €267.5m. The latest transaction was disclosed on 9 June 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: SPRINGER TIMOTHY A. The full history is free.
95
Insider Decl.
n/a
Thresholds
€2m
11 ops.
Buy Volume
€620,378
10 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Cartesian Therapeutics, Inc. Strong Buy (bullish), based on 7 analysts. Average price target: US$34.57.
41Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 9 June 2026
Declarations95 total
35,038 shares@ US$6.64210.091% mcap100.0% of flowCommonSEC144:0001950047-26-005808
3,924 shares@ US$6.410.0097% mcap9.7% of flowCommonSEC144:0001950047-26-005471
758,001 sharesCommon StockSEC:0002064832-26-000148:0
758,001 sharesCommon StockSEC:0002064832-26-000149:0
6,555 shares0Common StockSEC:0001453687-26-000066:0
23,766 shares@ US$6.819736.0% of flowCommon StockSEC:0001453687-26-000047:0
3,573 shares@ US$6.819714.5% of flowCommon StockSEC:0001453687-26-000046:0
10,591 shares@ US$6.819748.9% of flowCommon StockSEC:0001453687-26-000045:0
2,600 shares0Common StockSEC:0001453687-26-000039:0
143,200 shares0Common StockSEC:0001453687-26-000038:0
2,600 shares0Common StockSEC:0001453687-26-000037:0
27,000 shares0Common StockSEC:0001453687-26-000036:0
2,600 shares0Common StockSEC:0001453687-26-000035:0
6,500 shares0Common StockSEC:0001453687-26-000034:0
37,000 shares0Common StockSEC:0001453687-26-000033:0
2,600 shares0Common StockSEC:0001453687-26-000032:0
24,000 shares0Common StockSEC:0001453687-26-000031:0
2,600 shares0Common StockSEC:0001453687-26-000030:0
2,600 shares0Common StockSEC:0001453687-26-000029:0
2,600 shares0Common StockSEC:0001453687-26-000028:0
7,500 shares@ US$3.3016.8% of flowCommon StockSEC:0001453687-26-000002:0
5,800 shares0Common StockSEC:0001453687-25-000144:0
30,000 shares@ US$6.859966.9% of flowCommon StockSEC:0001453687-25-000132:0
Canonical exit: 4 Mar 2026 (T+90)
7,500 shares@ US$3.3020.4% of flowCommon StockSEC:0001453687-25-000130:0
20,000 shares0Common StockSEC:0001453687-25-000127:0
25 of 95 declarations
关于 Cartesian Therapeutics, Inc.
Cartesian Therapeutics, Inc. 是一家生物制药公司，专注于开发基于 RNA 的严重疾病疗法。该公司在纳斯达克上市，股票代码为 XNAS。